• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

14
1
1
1
1

COUNTRY

1

CATEGORIES

  • 22
  • 10
  • 5
  • 5
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

32
32
40
53

PUBLISHED

1
10
22
53

PRODUCT TYPE

37
12
2
2

Search "Company Financials: Array Biopharma Inc." returned 53 results.

Array BioPharma, Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Array BioPharma, Inc. Company Profile” is a comprehensive report on Array BioPharma, Inc.. The report provides complete information on the operations, organization structure and financial information...

October 2014
FROM

Array BioPharma Inc. - Product Pipeline Review - 2012

Array BioPharma Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Array BioPharma Inc. - Product Pipeline Review - 2012” provides data on the Array BioPharma...

October 2012
FROM

Array BioPharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

May 2015
FROM

Array BioPharma Inc. - Product Pipeline Review - H2 2011

Array BioPharma Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Array BioPharma Inc. - Product Pipeline Review - H2 2011” provides data on the Array...

November 2011
FROM

Array BioPharma Inc. (ARRY) - Financial and Strategic SWOT Analysis Review

Array BioPharma Inc. (ARRY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

December 2014
FROM

Array BioPharma Inc.

A textual analysis of the financial results for Array BioPharma Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio...

June 2015
FROM

Dilated Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

'Dilated Cardiomyopathy Therapeutics Market [Drug Class: Aldosterone Antagonists, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs) and Beta-Blockers] - Global...

March 2015
FROM

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM

Stifel, Nicolaus & Company Inc. Healthcare Conference - Array BioPharma, Inc., - Earnings Transcript

Stifel, Nicolaus & Company Inc. Healthcare Conference - Array BioPharma, Inc., - Earnings Transcript Thursday, September 08, 2011 05:30

September 2011

Cowen and Company Health Care Conference - Array BioPharma, Inc., - Earnings Transcript

Cowen and Company Health Care Conference - Array BioPharma, Inc., - Earnings Transcript Monday, March 05, 2012 09:50

March 2012

ARRY - Array BioPharma Inc - Company Analysis and ASR Ranking Report

Array BioPharma Inc., a discovery research company, creates drug candidates. The Company provides drug discovery products and services to create, evaluate, and optimize potential drug candidates in...

March 2013
FROM

BBB Technologies: Novel CNS Drug Delivery Approaches, 2015 - 2030

Several people across the globe suffer from different neurological disorders. However, the drugs currently available in the market provide only symptomatic relief and do not treat the root cause. This...

May 2015
FROM

Contract Manufacturing in Pharmaceutical Industry, 2015-2025

Amongst the increasing financial pressures and the need to reduce cost and improve efficiencies, the pharmaceutical industry has witnessed a paradigm shift from vertically integrated business model...

February 2015
FROM

Endocyte, Inc.

A textual analysis of the financial results for Endocyte, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses...

June 2015
FROM

Adamas Pharmaceuticals Inc

A textual analysis of the financial results for Adamas Pharmaceuticals Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

June 2015

Reliv' International, Inc.

A textual analysis of the financial results for Reliv' International, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

June 2015
FROM

Raptor Pharmaceutical Corp.

A textual analysis of the financial results for Raptor Pharmaceutical Corp. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

June 2015
FROM

Clovis Oncology, Inc. - Product Pipeline Review - 2012

Clovis Oncology, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Clovis Oncology, Inc. - Product Pipeline Review - 2012” provides data on the Clovis Oncology,...

December 2012
FROM

Plunkett's Biotech & Genetics Industry Almanac 2015: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies

Key Findings: - Plunkett Research lists top 400 companies in the Biotech & Genetics and names top trends changing the industry for the mid term. Key Features: - Industry trends analysis, market...

October 2014
FROM

Cell Culture: The Market for Media, Sera and Reagents

Cell Culture: The Market for Media, Sera and Reagents- The growth in biopharmaceuticals is creating an unprecedented increase in demand for cell culture products. Cell culture techniques have been...

April 2013
FROM
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.